Wide Host Range and Strong Lytic Activity of Staphylococcus aureus Lytic Phage Stau2

Author:

Hsieh Sue-Er1,Lo Hsueh-Hsia1,Chen Shui-Tu2,Lee Mong-Chuan3,Tseng Yi-Hsiung4

Affiliation:

1. Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung 406, Taiwan

2. Pediatrics Department, Nantou Hospital, Department of Health, Nantou 540, Taiwan

3. Institute of Life Sciences, Central Taiwan University of Science and Technology, Taichung 406, Taiwan

4. Institute of Microbiology, Immunology and Biochemistry, Tzu Chi University, Hualien 970, Taiwan

Abstract

ABSTRACT In searching for an alternative antibacterial agent against multidrug-resistant Staphylococcus aureus , we have isolated and characterized a lytic staphylophage, Stau2. It possesses a double-stranded DNA genome estimated to be about 134.5 kb and a morphology resembling that of members of the family Myoviridae . With an estimated latency period of 25 min and a burst size of 100 PFU/infected cell, propagation of Stau2 in liquid culture gave a lysate of ca. 6 × 10 10 PFU/ml. It was stable at pH 5 to 13 in normal saline at room temperature for at least 4 weeks and at −85°C for more than 2 years, while 1 × 10 9 out of 2 × 10 12 PFU/ml retained infectivity after 36 months at 4°C. Stau2 could lyse 80% of the S . aureus isolates (164/205) obtained from hospitals in Taiwan, with complete lysis of most of the isolates tested within 3 h; however, it was an S . aureus -specific phage because no lytic infection could be found in the coagulase-negative staphylococci tested. Its host range among S . aureus isolates was wider than that of polyvalent phage K (47%), which can also lyse many other staphylococcal species. Experiments with mice demonstrated that Stau2 could provide 100% protection from lethal infection when a multiplicity of infection of 10 was administered immediately after a challenge with S . aureus S23. Considering these results, Stau2 could be considered at least as a candidate for topical phage therapy or an additive in the food industry.

Publisher

American Society for Microbiology

Subject

Ecology,Applied Microbiology and Biotechnology,Food Science,Biotechnology

Reference28 articles.

1. Ackermann, H. W. 2001. Frequency of morphological phage descriptions in the year 2000. Brief review. Arch. Virol. 146:843-857.

2. Alisky, J., K. Iczkowski, A. Rapoport, and N. Troitsky. 1998. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:5-15.

3. Appelbaum, P. C. 2006. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12(Suppl. 1):16-23.

4. Bren, L. 2007. Bacteria-eating virus approved as food additive. FDA Consum. 41:20-22.

5. Brüssow, H. 2005. Phage therapy: the Escherichia coli experience. Microbiology 151:2133-2140.

Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3